Venus Concept Inc. (VERO)
USD 2.39
(5.75%)
USD 2.39
(5.75%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -26.11 Million USD | 20.45% |
| 2022 | -35.28 Million USD | -73.37% |
| 2021 | -13.03 Million USD | 56.63% |
| 2020 | -68.49 Million USD | -99.38% |
| 2019 | -30.55 Million USD | 23.32% |
| 2018 | -25.9 Million USD | -50.23% |
| 2017 | -15.18 Million USD | 5.87% |
| 2016 | -18.7 Million USD | 2.65% |
| 2015 | -19.21 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.62 Million USD | -140.2% |
| 2024 Q1 | -6.78 Million USD | 15.44% |
| 2023 Q3 | -5.75 Million USD | -21.53% |
| 2023 Q4 | -6.56 Million USD | -14.05% |
| 2023 Q2 | -4.73 Million USD | 33.79% |
| 2023 FY | - USD | 20.45% |
| 2023 Q1 | -7.14 Million USD | 19.59% |
| 2022 FY | - USD | -73.37% |
| 2022 Q4 | -8.88 Million USD | 14.07% |
| 2022 Q3 | -10.34 Million USD | -71.97% |
| 2022 Q2 | -6.01 Million USD | 5.05% |
| 2022 Q1 | -6.33 Million USD | -55.73% |
| 2021 Q2 | -102 Thousand USD | 98.16% |
| 2021 Q1 | -5.53 Million USD | 36.57% |
| 2021 FY | - USD | 56.63% |
| 2021 Q3 | -4.08 Million USD | -3903.92% |
| 2021 Q4 | -4.06 Million USD | 0.39% |
| 2020 Q3 | -4.11 Million USD | 48.09% |
| 2020 Q2 | -7.92 Million USD | 46.77% |
| 2020 FY | - USD | -99.38% |
| 2020 Q4 | -8.72 Million USD | -112.04% |
| 2020 Q1 | -14.88 Million USD | -37.67% |
| 2019 Q4 | -10.81 Million USD | -65.44% |
| 2019 FY | - USD | 23.32% |
| 2019 Q3 | -6.53 Million USD | -11.65% |
| 2019 Q2 | -5.85 Million USD | -16.85% |
| 2019 Q1 | -5.01 Million USD | 30.71% |
| 2018 Q1 | -6.92 Million USD | -178.34% |
| 2018 Q2 | -5.59 Million USD | 19.26% |
| 2018 Q3 | -6.16 Million USD | -10.15% |
| 2018 Q4 | -7.23 Million USD | -17.35% |
| 2018 FY | - USD | -50.23% |
| 2017 Q1 | -4.43 Million USD | -6.59% |
| 2017 FY | - USD | 5.87% |
| 2017 Q2 | -4.29 Million USD | 2.98% |
| 2017 Q3 | -5.94 Million USD | -38.17% |
| 2017 Q4 | -2.48 Million USD | 58.1% |
| 2016 FY | - USD | 2.65% |
| 2016 Q3 | -5.16 Million USD | 0.0% |
| 2016 Q4 | -4.15 Million USD | 19.55% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -93.616% |
| Cerus Corporation | -26.53 Million USD | 1.594% |
| OrthoPediatrics Corp. | -8.38 Million USD | -211.574% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -148.826% |
| Talis Biomedical Corporation | -66.04 Million USD | 60.462% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -56.6% |
| Inogen, Inc. | -45.67 Million USD | 42.834% |
| Spectral AI, Inc. | -12.26 Million USD | -112.959% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 45.248% |
| CVRx, Inc. | -38.73 Million USD | 32.579% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -640.164% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -115.685% |
| Orthofix Medical Inc. | -86.98 Million USD | 69.98% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 47.534% |
| Bioventus Inc. | -23.07 Million USD | -13.19% |
| BrainsWay Ltd. | -2.31 Million USD | -1029.944% |
| Envoy Medical, Inc. | -18.23 Million USD | -43.179% |
| electroCore, Inc. | -17.76 Million USD | -47.033% |
| IceCure Medical Ltd | -15.25 Million USD | -71.199% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 47.513% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -54.921% |
| MaxCyte, Inc. | -44.12 Million USD | 40.824% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -122.125% |
| Nexalin Technology, Inc. | -5.69 Million USD | -358.763% |
| PAVmed Inc | -75.74 Million USD | 65.524% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 51.425% |
| RxSight, Inc. | -41.03 Million USD | 36.367% |
| Sight Sciences, Inc. | -49.41 Million USD | 47.156% |
| SI-BONE, Inc. | -34.44 Million USD | 24.191% |
| TELA Bio, Inc. | -40.63 Million USD | 35.735% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 55.208% |
| Treace Medical Concepts, Inc. | -39 Million USD | 33.057% |
| LivaNova PLC | 39.01 Million USD | 166.929% |
| 908 Devices Inc. | -34.02 Million USD | 23.253% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 76.388% |
| Nemaura Medical Inc. | -7.28 Million USD | -258.348% |
| NeuroPace, Inc. | -22.83 Million USD | -14.36% |
| LENSAR, Inc. | -8.71 Million USD | -199.667% |
| Apyx Medical Corporation | -18.11 Million USD | -44.175% |
| Cutera, Inc. | -136.56 Million USD | 80.878% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -672.574% |
| BioSig Technologies, Inc. | -28.15 Million USD | 7.24% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1137.878% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -24.413% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 106.808% |
| Axonics, Inc. | 7.77 Million USD | 435.859% |
| Outset Medical, Inc. | -153.78 Million USD | 83.02% |
| IRIDEX Corporation | -7.44 Million USD | -250.604% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 73.38% |
| IRadimed Corporation | 20.8 Million USD | 225.539% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -223.902% |
| INVO Bioscience, Inc. | -6.88 Million USD | -279.548% |
| Telesis Bio, Inc. | -40.49 Million USD | 35.512% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 171.197% |
| Varex Imaging Corporation | 67.2 Million USD | 138.859% |
| Quipt Home Medical Corp. | 44.07 Million USD | 159.252% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -140.23% |
| Pulmonx Corporation | -55.09 Million USD | 52.601% |
| Dynatronics Corporation | -976 Thousand USD | -2575.49% |
| Modular Medical, Inc. | -17.1 Million USD | -52.681% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -80.276% |
| Semler Scientific, Inc. | 23.58 Million USD | 210.7% |
| InMode Ltd. | 196.28 Million USD | 113.304% |
| Bruker Corporation | 599 Million USD | 104.359% |
| Cytosorbents Corporation | -28.81 Million USD | 9.364% |
| DexCom, Inc. | 916.7 Million USD | 102.849% |
| Align Technology, Inc. | 799.03 Million USD | 103.268% |
| Viveve Medical, Inc. | -20.61 Million USD | -26.658% |
| ZimVie Inc. | 91.07 Million USD | 128.673% |
| Movano Inc. | -29.12 Million USD | 10.342% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -492.4% |
| Nexalin Technology, Inc. | -5.69 Million USD | -358.763% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -640.164% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 86.585% |
| Profound Medical Corp. | -27.12 Million USD | 3.725% |
| Insulet Corporation | 323.6 Million USD | 108.07% |
| enVVeno Medical Corporation | -25.01 Million USD | -4.377% |
| Surmodics, Inc. | 1.18 Million USD | 2298.064% |
| iCAD, Inc. | -6.56 Million USD | -297.761% |
| Nuwellis, Inc. | -16.35 Million USD | -59.654% |
| Biotricity, Inc. | -8.82 Million USD | -195.788% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 73.041% |
| Aethlon Medical, Inc. | -11.84 Million USD | -120.379% |
| InspireMD, Inc. | -20.91 Million USD | -24.877% |
| PAVmed Inc. | -75.74 Million USD | 65.524% |
| BIOLASE, Inc. | -15.13 Million USD | -72.488% |
| Beyond Air, Inc. | -59.03 Million USD | 55.764% |
| FONAR Corporation | 28.25 Million USD | 192.43% |
| AxoGen, Inc. | -13.32 Million USD | -95.926% |
| Vivani Medical, Inc. | -26.6 Million USD | 1.86% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 206.406% |
| Inari Medical, Inc. | 7.11 Million USD | 467.117% |
| UFP Technologies, Inc. | 72.74 Million USD | 135.898% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -671.254% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -324.188% |
| Tenon Medical, Inc. | -15.52 Million USD | -68.167% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -71.053% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 37.04% |
| AdaptHealth Corp. | -171.09 Million USD | 84.737% |
| Sintx Technologies, Inc. | -6.6 Million USD | -295.652% |
| NanoVibronix, Inc. | -3.43 Million USD | -660.204% |
| Quanterix Corporation | -38.08 Million USD | 31.44% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -140.23% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 87143.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 90.583% |
| TransMedics Group, Inc. | -7.6 Million USD | -243.457% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -19.977% |
| NeuroMetrix, Inc. | -7.09 Million USD | -268.006% |
| Hyperfine, Inc. | -47.06 Million USD | 44.512% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 55.215% |
| Biomerica, Inc. | -5.99 Million USD | -335.725% |
| Bone Biologics Corporation | 479.57 Thousand USD | 5545.064% |
| AVITA Medical, Inc. | -39.56 Million USD | 34.004% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -184.675% |
| Silk Road Medical, Inc | -45.08 Million USD | 42.074% |